683 CAPITAL MANAGEMENT LLC
Q2 2024 Form 13-F
NEW YORK, NEW YORK
CIK 0001404574
· CRD 156181
· SEC-registered investment adviser
Consolidated report · includes
1 manager
since Q2 2013
$1.3B Reported Value Total
683 CAPITAL MANAGEMENT, LLC reports 2 total accounts under management (AUM). There are 2 discretionary accounts valued at $1,951,751,504, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
2 funds
· $2.4B gross asset value
Hedge Fund: $2.4B
Source: Form ADV filed 2026-03-30
Reported value
$1.3B
Quarter over quarter
-4.8%
Holdings
124
Top-10 concentration
42.9%
Filing Structure
Reports holdings for
- 683 Capital Partners LP · File #028-14774 · since Q2 2013
Key People
Form ADV owners & control persons
John Andrew Levin
MANAGING MEMBER
Ari Jonathan Zweiman
MANAGING MEMBER
Joseph S Patt
PARTNER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q2 2024 13F record
Q2 2024 13F filing summary
| Period of report | June 30, 2024 |
|---|---|
| Filed | August 14, 2024 |
| Form | 13F-HR |
| Reported value | $1.3B |
| Positions | 124 |
| Change in reported value | -3.2% |
| New positions | 21 |
| Exited positions | 12 |
| Position turnover | 24.3% |
| Top-10 concentration | 42.9% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
122 | $2.4B |
|
Q2 2026 13F
Filed Aug 14, 2026
|
125 | $2.0B |
|
Q1 2026 13F
Filed May 15, 2026
|
204 | $1.9B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
201 | $2.3B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
113 | $1.9B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
111 | $1.5B |
|
Q1 2025 13F
Filed May 15, 2025
|
114 | $1.4B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
205 | $1.6B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
124 | $1.3B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
124 | $1.3B |
|
Q1 2024 13F
Filed May 15, 2024
|
118 | $1.4B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
236 | $1.2B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
127 | $1.3B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
135 | $1.4B |
|
Q1 2023 13F
Filed May 15, 2023
|
263 | $1.3B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
290 | $1.2B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
231 | $1.3B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
260 | $1.4B |
|
Q1 2022 13F
Filed May 16, 2022
|
342 | $1.9B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
327 | $2.7B |
34 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | LLY P ELI LILLY & CO | $172.9M | 13.07% |
| 2 | TSLA P TESLA INC | $71.8M | 5.43% |
| 3 | HGV HILTON GRAND VACATIONS INC | $52.6M | 3.97% |
| 4 | COF CAPITAL ONE FINL CORP | $46.4M | 3.51% |
| 5 | SN SHARKNINJA INC | $45.1M | 3.41% |
| 6 | ERO ERO COPPER CORP | $42.7M | 3.23% |
| 7 | BWA BORGWARNER INC | $35.5M | 2.68% |
| 8 | CVNA CARVANA CO | $35.4M | 2.68% |
| 9 | OXYWS OCCIDENTAL PETE CORP | $35.2M | 2.66% |
| 10 | ALNY P ALNYLAM PHARMACEUTICALS INC | $29.9M | 2.26% |
| 11 | MRNA P MODERNA INC | $28.7M | 2.17% |
| 12 | WVE WAVE LIFE SCIENCES LTD | $26.6M | 2.01% |
| 13 | TGTX TG THERAPEUTICS INC | $24.9M | 1.88% |
| 14 | BBIO 2.5 03/15/27 BRIDGEBIO PHARMA INC | $23.2M | 1.75% |
| 15 | INSM 0.75 06/01/28 INSMED INC | $22.1M | 1.67% |
| 16 | COI COGENT COMMUNICATIONS HLDGS | $21.2M | 1.6% |
| 17 | PTGX PROTAGONIST THERAPEUTICS INC | $20.9M | 1.58% |
| 18 | XHR XENIA HOTELS & RESORTS INC | $19.0M | 1.43% |
| 19 | VKTX VIKING THERAPEUTICS INC | $18.0M | 1.36% |
| 20 | MREO MEREO BIOPHARMA GROUP PLC | $18.0M | 1.36% |
Values as reported on the Q2 2024 Form 13F. Every position is in the holdings table below.